Search results for "Opioid use disorder"
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2023/11/latest-updates-on-acps-priorities-initiatives.htm
1 Nov 2023
OUD risk tests, gene therapies for sickle cell approved
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2024/02/oud-risk-tests-gene-therapies-for-sickle-cell-approved.htm
1 Feb 2024
Pandemic may have led to changes in buprenorphine treatment initiation, retention
While more U.S. patients received buprenorphine for opioid use disorder between March 13 and Dec. 1, 2020, than during the same period in 2019, there were about 17% fewer new prescriptions than expected, a recent study found.
https://immattersacp.org/weekly/archives/2022/12/13/2.htm
13 Dec 2022
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2023/10/latest-updates-on-acps-priorities-initiatives.htm
1 Oct 2023
Few internal medicine residency programs provide clinical opioid-related training
A 2019 survey of members of the Association of Program Directors in Internal Medicine found that while 82% of programs required some training in safe opioid prescribing and opioid use disorder treatment, few programs required clinical experiences.
https://immattersacp.org/weekly/archives/2021/11/09/5.htm
9 Nov 2021
High-dose opioid use dropping in the VA, but opioids frequently discontinued involuntarily, studies find
Recent studies from the Veterans Health Administration looked at voluntary and involuntary opioid reduction; high-dose, long-term opioid therapy; and quality improvement efforts for opioid use disorder treatment.
https://immattersacp.org/weekly/archives/2020/11/10/2.htm
10 Nov 2020
ACP's Pain Management Learning Hub releases new learning materials
Each of the new peer-to-peer activities provides opportunities for ACP members to earn free CME/MOC credit and meet many state-based CME requirements.
https://immattersacp.org/weekly/archives/2022/02/01/6.htm
1 Feb 2022
‘Gold standard’ underused for substance misuse
While effective medications to treat opioid addiction are available in primary care, few physicians prescribe buprenorphine or naltrexone, and few would obtain the Drug Enforcement Administration (DEA) waiver to prescribe buprenorphine.
https://immattersacp.org/archives/2020/11/gold-standard-underused-for-substance-misuse.htm
1 Nov 2020
Younger age, other factors associated with new OUD diagnosis after hospitalization
A retrospective cohort study looked at opioid-naive patients who received at least one prescription for an opioid during a surgical or nonsurgical inpatient hospitalization between 2014 and 2017.
https://immattersacp.org/weekly/archives/2022/05/24/4.htm
24 May 2022
Breaking barriers to buprenorphine
Despite heightened awareness of the opioid crisis, treatment still eludes many patients who are struggling with addiction.
https://immattersacp.org/archives/2018/09/breaking-barriers-to-buprenorphine.htm
1 Sep 2018